Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVI-Brain-1 in recurrent grade IV glioma
NCT01081223Phase 2Completed
- Sponsor
- TVAX Biomedical
- Start
- Apr 2010
- Primary completion
- Mar 2011
- Modality
- Prophylactic Vaccines, Cancer Vaccines, Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of TVI-Brain 1 in glioblastoma (GBM), sponsored by TVAX Biomedical. Started Apr 2010; status: completed.
02
Drugs
TVI-Brain 1
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01081223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081223.